Rigel Pharmaceuticals Inc
(NAS:RIGL)
$
11.25
0.66 (6.23%)
Market Cap: 197.53 Mil
Enterprise Value: 197.42 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 69/100 Rigel Pharmaceuticals Inc (RIGL) Transcripts
- Q1 2024 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2024$11.9 (-2.46%)Earnings
- Q4 2023 Rigel Pharmaceuticals Inc Earnings Call TranscriptMar 05, 2024$14.8 (+0.68%)Earnings
- Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Rigel Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2023$8.71 (+3.51%)Earnings
- Rigel Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 27, 2023
- Q2 2023 Rigel Pharmaceuticals Inc Earnings Call TranscriptAug 01, 2023$13.3 (-3.62%)Earnings
- Rigel Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2023$11.4 (-4.20%)Earnings
- Q4 2022 Rigel Pharmaceuticals Inc Earnings Call TranscriptMar 07, 2023$14.7 (-3.29%)Earnings
- Rigel Pharmaceuticals Inc To Discuss The FDA Approval of REZLIDHIA Call TranscriptDec 01, 2022
- Q3 2022 Rigel Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2022$7.26 (+3.23%)Earnings
- Q2 2022 Rigel Pharmaceuticals Inc Earnings Call TranscriptAug 02, 2022$13 (+7.44%)Earnings
- Rigel Pharmaceuticals Inc to Discuss FORWARD Study Results TranscriptJun 08, 2022
- Q1 2022 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 03, 2022$24.8 (+0.81%)Earnings
- Q4 2021 Rigel Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2022$25.1Earnings
- Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Q3 2021 Rigel Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2021$35.7 (+0.85%)Earnings
- Rigel Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 Rigel Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2021$37.8 (-5.97%)Earnings
- Rigel Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMay 18, 2021
- Q1 2021 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021$34.7 (+0.87%)Earnings
- Rigel Pharmaceuticals Inc Positive Topline Data Shows Fostamatinib Meets Primary Endpoint of Safety in Phase 2 Clinical Trial in Hospitalized Patients with COVID-19 -Corporate Call TranscriptApr 13, 2021
- Q4 2020 Rigel Pharmaceuticals Inc Earnings Call TranscriptMar 02, 2021$43.05 (-3.69%)Earnings
- Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q3 2020 Rigel Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020$27.4 (+1.48%)Earnings
- Rigel Pharmaceuticals Inc at Citi BioPharma Conference (Virtual)- Panel: State of Play for COVID-19 Therapeutics TranscriptSep 09, 2020
- Q2 2020 Rigel Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2020$24.6 (+1.23%)Earnings
- Rigel Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMay 14, 2020
- Q1 2020 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2020$19.6 (+5.95%)Earnings
- Q4 2019 Rigel Pharmaceuticals Inc Earnings Call TranscriptFeb 27, 2020$20.4 (-5.99%)Earnings
- Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Q3 2019 Rigel Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2019$21.7 (+0.93%)Earnings
- Rigel Pharmaceuticals Inc Investor and Analyst Call TranscriptOct 23, 2019
- Editas Medicine Inc, Apellis Pharmaceuticals Inc and Rigel Pharmaceuticals Inc at Citi Biotech Conference TranscriptSep 05, 2019
- Q2 2019 Rigel Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2019$21.7 (+3.33%)Earnings
- Q1 2019 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2019$23.2 (-2.52%)Earnings
- Q4 2018 Rigel Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2019$21.9 (-3.10%)Earnings
- 1